The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Use of Medication for Cardiovascular Disease During Pregnancy
Open accessAbstract
Cardiovascular disease complicating pregnancy is rising in prevalence secondary to advanced maternal age, cardiovascular risk factors, and the successful management of congenital heart disease conditions. The physiological changes of pregnancy may alter drug properties affecting both mother and fetus. Familiarity with both physiological and pharmacological attributes is key for the successful management of pregnant women with cardiac disease. This review summarizes the published data, available guidelines, and recommendations for use of cardiovascular medications during pregnancy. Care of the pregnant woman with cardiovascular disease requires a multidisciplinary team approach with members from cardiology, maternal fetal medicine, anesthesia, and nursing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Transient neonatal hypothyroidism after gestational exposure to amiodarone: A follow-up of two cases
Grosso, S., Berardi, R., Cioni, M., & Morgese, G. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350801 · Cited by 31
Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure
Kofinas, A. D., Simon, N. V., Sagel, H., et al. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90298-6 · Cited by 30
Fetal tachycardia: A role for amiodarone as first- or second-line therapy?
Pezard, P., Boussion, F., Sentilhes, L., Lépinard, C., Couvreur, M.-H., Victor, J., Geslin, P., & Descamps, P. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.08.012 · Cited by 30
Indirect maternal mortality increases in the Netherlands
Schutte, J. M., de Jonge, L. L., Schuitemaker, N., Santema, J. G., Steegers, E. A. P., & van Roosmalen, J. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016341003657876 · Cited by 30
Mousa, H., McKinley, C. A., & Thong, J. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11096.x · Cited by 29
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction
Prefumo, F., Muiesan, M. L., Perini, R., Paini, A., Bonzi, B., Lojacono, A., Agabiti‐Rosei, E., & Frusca, T. (2007) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.5231 · Cited by 29
Treatment options for hypertension in pregnancy and puerperium
Amro, F. H., Moussa, H. N., Ashimi, O. A., & Sibai, B. M. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1237500 · Cited by 29
Gregg, A. R., & Tomich, P. G. (1988) · PubMed · Cited by 27
Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient [letter]
Lt, B., Meniconi, L., Chiocchi, P., Liberati, R., Zuanetti, G., & Latini, R. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03413.x · Cited by 27
Heart rate changes mediate the embryotoxic effect of antiarrhythmic drugs in the chick embryo
Kočková, R., Svatunkova, J., Novotný, J., Hejnová, L., Ostadal, B., & Sedmera, D. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00679.2012 · Cited by 27
Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures
Bateman, B. T., Huybrechts, K. F., Maeda, A., Desai, R. J., Patorno, E., Seely, E. W., Ecker, J. L., Allen‐Savietta, C., Mogun, H., Hernández–Dı́az, S., et al. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000908 · Cited by 23
Outpatient calcium‐channel blockers and the risk of postpartum haemorrhage: a cohort study
Bateman, B. T., Hernández–Díaz, S., Huybrechts, K. F., Palmsten, K. K., Mogun, H., Ecker, J. L., Seely, E., & Fischer, M. (2013) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12428 · Cited by 23
Plasma concentration ? effect relationship of metoprolol during and after pregnancy
H�gstedt, S., & Rane, A. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00271365 · Cited by 21
Water and Electrolyte Balance During Pregnancy
Little, B. (1965) · Anesthesiology · doi:10.1097/00000542-196507000-00005 · Cited by 21
Pregnancy-Related Venous Thromboembolism
Armstrong, E. M., Bellone, J. M., Hornsby, L. B., Eudaley, S. T., & Phillippe, H. M. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014530425 · Cited by 21
Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
Monsivais, L. A., Pacheco, L., & Saad, A. F. (2016) · American Journal of Perinatology Reports · doi:10.1055/s-0036-1586241 · Cited by 21
Pharmacokinetic and Pharmacodynamic Evaluation of Atenolol during and after Pregnancy
Hurst, A. K., Shotan, A., Hoffman, K., Johnson, J. K., Goodwin, T. M., Koda, R. T., & Elkayam, U. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03906.x · Cited by 19
van Vliet, E. O. G., Schuit, E., Heida, K. Y., Opmeer, B. C., Kok, M., Gyselaers, W., PORATH, M. M., Woiski, M., Bax, C. J., Bloemenkamp, K. W. M., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-93 · Cited by 19
Obstetric anaesthesia and peripartum management
Turnbull, J., & Bell, R. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.03.008 · Cited by 18
Sørensen, H. T., Steffensen, F. H., Olesen, C., Nielsen, G. L., Pedersen, L. H., & Olsen, J. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00012-4 · Cited by 18
Drugs in pregnancy: Implications for a cardiologist.
Rakusan, K. (2010) · Europe PMC (PubMed Central) · Cited by 16
Pharmacogenetics and Other Reasons Why Drugs Can Fail in Pregnancy: Higher Dose or Different Drug?
Haas, D. M., & D’Alton, M. E. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182698538 · Cited by 16
Valensise, H. C. C., Civitella, C., Garzetti, G. G., & Romaninï, C. (1992) · Prenatal Diagnosis · doi:10.1002/pd.1970120903 · Cited by 12
Continuous Epidural Lidocaine Infusion in the Parturient with Paroxysmal Ventricular Tachycardia
Juneja, M. M., Ackerman, W. E., Kaczorowski, D. M., Sollo, D. G., & GUNZENHAUSER, L. F. (1989) · Anesthesiology · doi:10.1097/00000542-198908000-00024 · Cited by 11
Clearance Prediction and Drug Dosage in Pregnancy
Gonser, M., Stoll, P., & Kahle, P. J. (1995) · Clinical Drug Investigation · doi:10.2165/00044011-199509040-00003 · Cited by 10
Capone, C. A., Gebb, J. S., Dar, P., & Shenoy, R. (2014) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-14814017 · Cited by 8
Propafenone in Wolff-Parkinson-White syndrome at risk
Santinelli, V., Turco, P., Paola, M. D., Smimmo, D., Giasi, M., Santinelli, C., Massimo Chiariello, A., & Condorelli, M. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01856555 · Cited by 8
Horng, M., Mohammad, I., Smith, Z., Awdish, R., & Cajigas, H. R. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1793 · Cited by 8
Adenosine for Maternal Supraventricular Tachycardia and Preterm Delivery
Matsubara, S., Kuwata, T., & Mitsuhashi, T. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34980-5 · Cited by 7
Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges
Koren, G., Clark, S. M., & Matsui, D. M. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/206179 · Cited by 6
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Metadata
- Authors
- Halpern, D. G., Weinberg, C. R., Pinnelas, R., Mehta-Lee, S., Economy, K. E., & Valente, A. M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 73
- Issue
- 4
- Pages
- 457-476
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2914027167
- Cited by
- 309
- References
- 230
- FWCI
- 21.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.